2413192-50-2

HBV-IN-15 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-15 is a flavone derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2020052774A1, compound 2)[1].

[1] Dongdong Chen, et al. Flavone derivatives for the treatment and prophylaxis of hepatitis b virus disease. Patent WO2020052774A1.